177 related articles for article (PubMed ID: 8937931)
1. Posttransplant erythrocytosis: a model for the investigation of the pharmacological control of renal erythropoietin production?
Gleiter CH
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):489-92. PubMed ID: 8937931
[TBL] [Abstract][Full Text] [Related]
2. Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.
Wang AY; Yu AW; Lam CW; Yu LM; Li PK; Goh J; Lui SF
Am J Kidney Dis; 2002 Mar; 39(3):600-8. PubMed ID: 11877580
[TBL] [Abstract][Full Text] [Related]
3. Factors predisposing to post-renal transplant erythrocytosis. A prospective matched-pair control study.
Kessler M; Hestin D; Mayeux D; Mertes PM; Renoult E
Clin Nephrol; 1996 Feb; 45(2):83-9. PubMed ID: 8846535
[TBL] [Abstract][Full Text] [Related]
4. Ramipril in post-renal transplant erythrocytosis.
Esposito R; Giammarino A; De Blasio A; Martinelli V; Cirillo F; Scopacasa F; Federico S; Russo D
J Nephrol; 2007; 20(1):57-62. PubMed ID: 17347974
[TBL] [Abstract][Full Text] [Related]
5. Serum stem cell factor level in renal transplant recipients with posttransplant erythrocytosis.
Kiykim AA; Genctoy G; Horoz M; Tiftik NE; Gok E; Altun B; Arici M; Haznedaroglu I
Artif Organs; 2009 Dec; 33(12):1086-90. PubMed ID: 19958348
[TBL] [Abstract][Full Text] [Related]
6. Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation.
Bakris GL; Sauter ER; Hussey JL; Fisher JW; Gaber AO; Winsett R
N Engl J Med; 1990 Jul; 323(2):86-90. PubMed ID: 2163024
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism.
Danovitch GM; Jamgotchian NJ; Eggena PH; Paul W; Barrett JD; Wilkinson A; Lee DB
Transplantation; 1995 Jul; 60(2):132-7. PubMed ID: 7624954
[TBL] [Abstract][Full Text] [Related]
8. Long-term therapy for postrenal transplant erythrocytosis with ACE inhibitors: efficacy, safety and action mechanisms.
Montanaro D; Groupuzzo M; Boscutti G; Risaliti A; Bresadola F; Mioni G
Clin Nephrol; 2000 Apr; 53(4):suppl 47-51. PubMed ID: 10809436
[TBL] [Abstract][Full Text] [Related]
9. Effect of the angiotensin-converting enzyme inhibitor enalapril on post-transplant erythrocytosis.
Marubayashi S; Yamamoto H; Shibata S; Fudaba Y; Miyata Y; Fukuma K; Okada K; Hinoi T; Ikeda M; Maeda T; Oshiro Y; Dohi K
Hiroshima J Med Sci; 1998 Sep; 47(3):121-4. PubMed ID: 9810784
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of post-transplant erythrocytosis: comparison of lisinopril and theophylline].
D'Amelio A; Bonucchi D; Patruno P; Ballestri M; Mastrangelo F
Minerva Cardioangiol; 1997 Nov; 45(11):567-72. PubMed ID: 9549290
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of captopril on posttransplant erythrocytosis. Long-term follow-up.
Torregrosa JV; Campistol JM; Montesinos M; Rogada AG; Oppenheimer F; Andreu J
Transplantation; 1994 Aug; 58(3):311-4. PubMed ID: 8053053
[TBL] [Abstract][Full Text] [Related]
12. Erythropoiesis after kidney transplantation: the role of erythropoietin, burst promoting activity and early erythroid progenitor cells.
Lezaic V; Biljanovic-Paunovic L; Pavlovic-Kentera V; Djukanovic L
Eur J Med Res; 2001 Jan; 6(1):27-32. PubMed ID: 11313188
[TBL] [Abstract][Full Text] [Related]
13. Posttransplant erythrocytosis in renal transplant recipients at Jeddah Kidney Center, Kingdom of Saudi Arabia.
Basri N; Gendo MZ; Haider R; Abdullah KA; Hassan A; Shaheen FA
Exp Clin Transplant; 2007 Jun; 5(1):607-9. PubMed ID: 17617052
[TBL] [Abstract][Full Text] [Related]
14. Influence of angiotensin-converting enzyme polymorphism gene, IGF-1, and other factors in the response rate of hematocrit to enalapril treatment in patients with posttransplant erythrocytosis.
Jimeno L; Rodado R; Barrios Y; Campos M; Llorente S; Nicolas F; Minguela A
Transplant Proc; 2005 Mar; 37(2):1012-3. PubMed ID: 15848608
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of enalapril after ineffective theophylline treatment on erythrocytosis after renal transplantation.
Yagisawa T; Toma H; Yaguchi H; Tomaru M; Iijima Y; Suzuki H; Nakada T
Int Urol Nephrol; 1997; 29(3):363-7. PubMed ID: 9285312
[TBL] [Abstract][Full Text] [Related]
16. Effect of enalapril on exaggerated erythropoietin response to phlebotomy in erythrocytosic renal transplant patients.
Usalan C; Erdem Y; Cağlar M; Altun B; Arici M; Bakkaloğlu M; Yasavul U; Turgan C; Cağlar S
Nephrol Dial Transplant; 1998 Nov; 13(11):2884-9. PubMed ID: 9829495
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of enalapril and theophylline on polycythemia after renal transplantation.
Ok E; Akçiçek F; Töz H; Kürşat S; Töbü M; Başçi A; Mees EJ
Transplantation; 1995 Jun; 59(11):1623-6. PubMed ID: 7778179
[TBL] [Abstract][Full Text] [Related]
18. Factors inducing posttransplant erythrocytosis.
Lezaić V; Djukanović LJ; Pavlović-Kentera V; Clemons G; Biljanović-Paunović L
Eur J Med Res; 1997 Sep; 2(9):407-12. PubMed ID: 9300939
[TBL] [Abstract][Full Text] [Related]
19. Expression of angiotensin II type I receptor on erythroid progenitors of patients with post transplant erythrocytosis.
Gupta M; Miller BA; Ahsan N; Ulsh PJ; Zhang MY; Cheung JY; Yang HC
Transplantation; 2000 Oct; 70(8):1188-94. PubMed ID: 11063339
[TBL] [Abstract][Full Text] [Related]
20. Posttransplant erythrocytosis: an enigma revisited.
Gaston RS; Julian BA; Curtis JJ
Am J Kidney Dis; 1994 Jul; 24(1):1-11. PubMed ID: 8023814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
